Lightspeed Announces Fiscal Fourth Quarter and Full Year 2025 Financial Results Conference Call
MONTREAL, April 10, 2025 /PRNewswire/ – Lightspeed Commerce Inc. (NYSE: LSPD) | (TSX: LSPD) (“Lightspeed” or the “Company“), the one-stop... Read more.
Two Become One: CITGO Makes Paying for Fuel Easier with Mobile App Consolidation
HOUSTON, April 10, 2025 /PRNewswire/ — Paying for fuel while earning loyalty rewards just got easier with the Club CITGO app, which now incorporates all the... Read more.
CloneOps.ai Officially Launches Its AI-Driven Business Communication Platform at TIA 2025 Capital Ideas Conference
FORT LAUDERDALE, Fla., April 10, 2025 /PRNewswire/ — In a bold move that redefines the future of business operations, CloneOps.ai announced yesterday the official... Read more.
RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights
Revenue-generating with an exciting, diversified, largely externally funded, advanced development pipeline and multiple upcoming catalysts. Recent highlights: Global... Read more.
StickerYou’s New Brand Campaign Proves Any Business Can Look Legit – Really, ANY Business
TORONTO, April 10, 2025 /PRNewswire/ – The streets of New York City were abuzz this week with news that the notorious Gambino family was planning to take... Read more.
SUNY Brockport Partners with eCampus.com to Launch Campus Store and Online Bookstore Focused on Student Success
eCampus.com’s full-service online bookstore platform will improve the student experience through access to low-cost course materials coupled with a customer-focused... Read more.
Tucows Announces Director Nominations and Honors Departing Board Members
TORONTO, April 10, 2025 /PRNewswire/ – Tucows Inc. (NASDAQ: TCX, TSX: TC) today announced the nomination of five new individuals for election to its Board... Read more.
Verde Sets Industry First with Puro.earth Carbon Credits from Asphalt
ST. LOUIS, April 10, 2025 /PRNewswire/ — Verde Resources Inc. proudly announces the successful completion of its proof-of-concept project at the National Center... Read more.
Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
Six-month open-label study showed clinically meaningful improvements in kidney function and disease in patients with Type 2 diabetic nephropathy. 71% achieved a... Read more.
BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn® in ALS
NEW YORK, April 10, 2025 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company developing cutting-edge cell therapies... Read more.